The genomics revolution, in the past two decades, has produced an unprecedented number of assets so as to propel future innovations. The current genomics-based applications show a huge potential in contributing to addressing some of the most critical global challenges such as human health, environmental issues, and agriculture. Genomics has, in a remarkably short period of time, led to various forms of revelations across the entire clinical continuum, from risk assessment in healthy individuals to genome-guided treatment of complex diseases. With an enormous treasure trove of data about human genome produced by genomic research spawning a whole new era of digital technologies and sequencing platforms, researchers and clinicians now have more robust tools to study the role that genetic factors play in complex diseases. Today, in medicine, genomics application is actively making efforts in saving lives and driving billions of dollars of economic activity globally. The ability to sequence and analyze the human genome, the entire sequence of its DNA, is transforming the medicine practice across the world. In fact, genome sequencing, today, has become comparatively commonplace, and is expected to further become more in the years to come. Furthermore, in the near future, genomics is expected to be the cornerstone of the cutting-edge precision medicine programs and may have a significant impact on improving treatment outcomes.
In this white paper, we will focus on the following key objectives
• What are the five key elements of genomics medicine that can drive value and
implementation of genomics in medical practice?
• Insights into how innovation in technologies, government initiatives, and reimbursement
landscape can influence the adoption of genomics across the clinical continuum